A Giustina, MD Bronstein, FF Casanueva… - Pituitary, 2011 - Springer Abstract To determine whether peer-reviewed consensus statements have changed clinical practice, we surveyed acromegaly care in specialist centers across the globe, and determined the degree of adherence to published consensus guidelines on acromegaly ... Related articles - All 4 versions
C Chieffo, M Ryan, S Bai, X Hu… - Endocrine …, 2011 - endocrine-abstracts.org Two randomized open-label, phase II studies evaluated an octreotide hydrogel implant to suppress serum GH and IGF1 levels in adult acromegaly patients. Implants were inserted subcutaneously in the upper arm for 6 months. Patients in study 1 received 1 (n=5) or 2 (n=6) 52-mg ... Cached
V Heath - Nature Reviews Endocrinology, 2011 - nature.com Acromegaly is often associated with impaired glucose metabolism. Normalization of this metabolic defect may occur after acromegaly is cured; however, predicting which patients will respond has proven difficult. “In clinical practice, we were experiencing that impaired glucose ... All 3 versions
D Halsall, R Kay, K Taylor, A Annamalai… - 2011 - endocrine-abstracts.org Methods: Here, we report the development of a stable isotope dilution ultra-performance liquid chromatography tandem MS (UPLC–MS/MS)-based method for the quantitation of serum IGF1. The method employs selected reaction monitoring (SRM) of two tryptic peptides ... Cached
HJ Schneider, RP Kosilek, M Günther… - Journal of Clinical …, 2011 - Endocrine Soc Address all correspondence and requests for reprints to: PD Dr. Med. Harald Jörn Schneider, MD, Medizinische Klinik, Innenstadt, Ludwig-Maximilians University, Ziemssenstrasse 1, 80336 Munich, Germany. E-mail: harald.schneider{at}med.uni-muenchen.de. Cited by 1 - Related articles - All 3 versions